A multi-country % multi-center study to assess the efficacy, safety % immunogenicity of 2 doses of GSK Biologicals’ oral live attenuated human rotavirus (HRV) vaccine in healthy infants in co-administration with specific childhood vaccines
Rotavirus Vaccine
Infections, Rotavirus
Phase 3
A follow-up study 109810 was conducted. An annotated case report form is not available for this study. A blank case report form will be provided.
January 2014